Analgesics in Japan - New Market Research Report
Analgesics in Japan declined by below 1% in current retail value terms in 2013. Systemic analgesics showed modest positive growth while topical analgesics/anaesthetic continued to shrink, which resulted in negative growth for the overall category. The fastest-growing categories were ibuprofen and combination products - analgesics due to the strong performances of leading brands. The positive growth of ibuprofen was due to the steady sales increase of Ringl IB by Sato Pharmaceutical Co Ltd. In particular, Ringl IB 200 contains the...
View full press release